Cassava Sciences Inc vs OneSpan Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while OneSpan Inc trades at $16.25 (market cap $600.69M). The key difference: OneSpan Inc is far larger — about 12.6× Cassava Sciences Inc's market cap, and OneSpan Inc pays a 3.19% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | OSPN | |
|---|---|---|
Market Cap | $47.75M | $600.69M |
Sector | Health | Technology |
52-Week High | $4.64 | $16.78 |
52-Week Low | $0.87 | $10.15 |
Enterprise Value | -$34.93M | $569.77M |
Dividend Yield | — | 3.19% |
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →